1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Apogenix GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease Asunercept, Placebo - COVID-19 | Phase 3 | Terminated | Apogenix GmbH | 34 | 2022-11-03 | 2023-08-29 |
COVID-19 (1)
Austria (1) · France (1) · Georgia (1) · Germany (1) · India (1) · Italy (1) · Poland (1) · South Africa (1) · Spain (1)
Eike C. Buss, MD (1)